Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK012 Phase II Study in Colorectal Cancer
jRCT2080220752Phase 2
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Jun 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, single-arm trial of NK012 in colorectal cancer (CRC), sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
NK012
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2080220752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220752.